• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, August 23, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Inflammatory mechanisms may underlie increased risk of prostate cancer among WTC responders

Bioengineer by Bioengineer
June 20, 2019
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Bottom Line: Inflammatory and immune-regulatory mechanisms were found to be altered in animal models and in archived prostate cancer tumor samples of responders exposed to dust from the World Trade Center terrorist attacks on Sept. 11, 2001.

Journal in Which the Study was Published: Molecular Cancer Research, a journal of the American Association for Cancer Research

Authors: Emanuela Taioli, MD, PhD, director of the Institute for Translational Epidemiology at the Icahn School of Medicine at Mount Sinai and associate director for Population Science at the Tisch Cancer Institute, both in New York; and William Oh, MD, chief of the Division of Hematology and Medical Oncology at the Icahn School of Medicine at Mount Sinai and deputy director at the Tisch Cancer Institute

Background: “World Trade Center responders show an overall increase in cancer incidence, including prostate cancer,” said Taioli. “It is important to address the reasons for this increased incidence in order to prevent new cases in this aging cohort.”

Previous work has reported an increased incidence of prostate cancer among responders to attacks on the World Trade Center. However, because these responders have been closely monitored, it remains unknown whether this increased incidence is truly related to exposure to carcinogens in the World Trade Center dust or whether it is a result of surveillance bias, noted Taioli. “Our study aimed to determine potential underlying mechanisms that could explain the link between World Trade Center responders and increased prostate cancer incidence,” she said.

How the Study Was Conducted and Results: To identify differential patterns of gene expression potentially caused by exposure to World Trade Center dust, the researchers compared archived prostate cancer tumors from unexposed individuals (14 patients) and World Trade Center responders (15 patients). Prostate cancer tumors taken from responders showed a downregulation of genes involved in immune-cell chemotaxis and proliferation and an upregulation of genes involved in apoptosis and immune modulation, compared with prostate cancer tumors taken from unexposed patients. Additionally, cell-type enrichment analyses revealed an upregulation of pro-inflammatory cell types in prostate cancer tissue samples taken from responders compared with samples taken from unexposed patients.

To understand how inhalation of World Trade Center dust may affect a healthy prostate, the researchers exposed rats to dust that was collected at Ground Zero within 72 hours after the attacks. Rats anesthetized using isoflurane received either a two-hour exposure to the dust or no exposure to the dust for two consecutive days. The dose was adjusted to mimic the level of dust first responders would have inhaled during the initial three days at Ground Zero. To identify both immediate and delayed responses to World Trade Center dust, rat prostates were harvested at one day or 30 days post exposure and analyzed.

Rat prostate samples taken after one day of exposure revealed an upregulation of pro-inflammatory cell types compared with controls. Prostate samples taken 30 days post exposure revealed an upregulation of genes involved in cholesterol biosynthesis compared with controls.

“Cholesterol is an important precursor to androgens, which are known to drive prostate cancer development,” explained Oh. “Our preliminary finding that exposure to World Trade Center dust increased the expression of genes in the cholesterol biosynthesis pathway highlights an additional mechanism by which environmental exposures may lead to the progression of prostate cancer.”

Author’s Comments: “It has been recognized that inflammation may be an important consideration in prostate cancer progression,” said Oh.

“In our study, both the archived human prostate cancer tissues of 9/11 responders and the prostates of rats experimentally exposed to World Trade Center dust showed an increase in pro-inflammatory cell types,” noted Taioli. “This finding represents the first mechanistic link between exposure to World Trade Center dust and prostate cancer.”

Oh noted, “Our results suggest that inflammatory mechanisms are activated in the prostate after exposure to World Trade Center dust, which may give rise to chronic inflammation and contribute to prostate cancer progression.”

Study Limitations: Limitations of the study include a small sample size of archived human prostate samples.

Funding & Disclosures: This study was sponsored by grants from the Centers for Disease Control and Prevention and the National Institute for Occupational Safety and Health.
Oh is a consultant/advisory board member for Sema4, CheckPoint Sciences, AstraZeneca, Sanofi, Genzyme, Bayer, and Janssen.

###

Media Contact
Julia Gunther
[email protected]
http://dx.doi.org/10.1158/1541-7786.MCR-19-0115

Tags: cancerCarcinogensMedicine/HealthProstate Cancer
Share12Tweet8Share2ShareShareShare2

Related Posts

blank

Deep Genome Sequencing Uncovers Placental Genetic Diversity

August 23, 2025
Children’s SARS-CoV-2 Antibodies Show Stronger FcR Binding

Children’s SARS-CoV-2 Antibodies Show Stronger FcR Binding

August 23, 2025

Link Between Type 2 Diabetes and Heart Failure

August 23, 2025

Exploring Type 3 APS, T1DM, and LADA Insights

August 23, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Molecules in Focus: Capturing the Timeless Dance of Particles

    141 shares
    Share 56 Tweet 35
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    114 shares
    Share 46 Tweet 29
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    81 shares
    Share 32 Tweet 20
  • Modified DASH Diet Reduces Blood Sugar Levels in Adults with Type 2 Diabetes, Clinical Trial Finds

    60 shares
    Share 24 Tweet 15

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Deep Genome Sequencing Uncovers Placental Genetic Diversity

Leaves Release Ice-Nucleating Particles in Rain

Advancing Supercapacitor Electrodes with Doped BiFeO3 Nanoparticles

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.